|
Class 2 Device Recall 216 Wilson Frame Pads, Model 531937 |
|
Date Initiated by Firm |
March 28, 2017 |
Date Posted |
April 19, 2017 |
Recall Status1 |
Terminated 3 on August 15, 2017 |
Recall Number |
Z-1867-2017 |
Recall Event ID |
76920 |
Product Classification |
Operating Room Accessories Table Tray - Product Code FWZ
|
Product |
216 Wilson Frame Pads, Model # 5319-37;
Used with Radiolucent Wilson Frames, model numbers 5319G and 5321G.
General and Plastic Surgery: These pads are used as a component of the Wilson Frames, which support the torso of a prone patient during spine surgery. The pads are supplied with the frames and as replacements. |
Code Information |
All Lots: Manufacturing dates: December 2016 through March 2017; GTIN:00842430100192 |
Recalling Firm/ Manufacturer |
Mizuho OSI 30031 Ahern Ave Union City CA 94587-1234
|
For Additional Information Contact |
Gina Costelli 800-777-4674
|
Manufacturer Reason for Recall |
Mizuho has discovered that the 5319-37 Wilson Frame Pads have a design deficiency in the construction of their mounting sleeves that may allow the patient to contact the underlying carbon fiber structure of the Wilson frame and could lead to a pressure injury.
|
FDA Determined Cause 2 |
Process control |
Action |
Letters were sent to customers and distributors on March 28, 2017 by Federal Express or UPS. Information is also posted on firm's web site. Frames having 5319-37 pads should not be used and all of the affected pads retrieved and destroyed. |
Quantity in Commerce |
216 sets |
Distribution |
United States, Canada, Japan, Australia, New Zealand, Great Britain, Sweden, Spain, Germany, Switzerland, Kenya, Saudi Arabia, Hong Kong, South Korea. |
Total Product Life Cycle |
TPLC Device Report
|
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
|
|
|